1,000 Shares in Teleflex Incorporated (NYSE:TFX) Purchased by Stock Yards Bank & Trust Co.

Stock Yards Bank & Trust Co. bought a new position in Teleflex Incorporated (NYSE:TFX) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 1,000 shares of the medical technology company’s stock, valued at approximately $249,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. LGT Capital Partners LTD. increased its stake in Teleflex by 285.4% in the 4th quarter. LGT Capital Partners LTD. now owns 257,864 shares of the medical technology company’s stock valued at $64,296,000 after buying an additional 190,950 shares during the last quarter. Invesco Ltd. increased its stake in Teleflex by 23.3% in the 3rd quarter. Invesco Ltd. now owns 621,445 shares of the medical technology company’s stock valued at $122,058,000 after buying an additional 117,401 shares during the last quarter. Adage Capital Partners GP L.L.C. purchased a new stake in Teleflex in the 3rd quarter valued at about $9,173,000. Cooke & Bieler LP increased its stake in Teleflex by 5.7% in the 4th quarter. Cooke & Bieler LP now owns 734,965 shares of the medical technology company’s stock valued at $183,256,000 after buying an additional 39,308 shares during the last quarter. Finally, Boston Trust Walden Corp increased its stake in Teleflex by 17.6% in the 4th quarter. Boston Trust Walden Corp now owns 227,888 shares of the medical technology company’s stock valued at $56,822,000 after buying an additional 34,100 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Royal Bank of Canada decreased their price objective on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a research note on Friday, February 23rd. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. Truist Financial decreased their price objective on shares of Teleflex from $270.00 to $265.00 and set a “hold” rating for the company in a research note on Friday, February 23rd. Finally, JMP Securities reissued a “market outperform” rating and set a $285.00 target price on shares of Teleflex in a research report on Friday, February 23rd. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $267.50.

Teleflex Stock Up 0.0 %

TFX opened at $211.17 on Thursday. The company has a 50 day moving average of $223.09 and a 200 day moving average of $225.66. The company has a market cap of $9.95 billion, a PE ratio of 28.04, a price-to-earnings-growth ratio of 2.02 and a beta of 1.11. Teleflex Incorporated has a 12 month low of $177.63 and a 12 month high of $276.43. The company has a current ratio of 2.32, a quick ratio of 1.29 and a debt-to-equity ratio of 0.39.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $3.38 EPS for the quarter, topping the consensus estimate of $3.26 by $0.12. The company had revenue of $773.90 million during the quarter, compared to the consensus estimate of $769.01 million. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. Teleflex’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same period last year, the firm earned $3.52 EPS. On average, sell-side analysts expect that Teleflex Incorporated will post 13.73 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, March 1st were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.64%. The ex-dividend date was Thursday, February 29th. Teleflex’s dividend payout ratio (DPR) is presently 18.06%.

Insider Buying and Selling

In related news, VP Cameron P. Hicks sold 7,401 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total value of $1,665,225.00. Following the completion of the transaction, the vice president now directly owns 10,050 shares of the company’s stock, valued at approximately $2,261,250. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.43% of the stock is owned by insiders.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.